Therapeutic potential of tumor treating fields for malignant brain tumors
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic potential of tumor treating fields for malignant brain tumors
Authors
Keywords
-
Journal
Cancer Reports
Volume 6, Issue 5, Pages -
Publisher
Wiley
Online
2023-03-29
DOI
10.1002/cnr2.1813
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier
- (2023) Ellaine Salvador et al. Pharmaceutics
- Genome-Wide Expression and Anti-Proliferative Effects of Electric Field Therapy on Pediatric and Adult Brain Tumors
- (2022) Joshua Branter et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Brain metastases: Not all tumors are created equal
- (2022) Daniel Kirschenbaum et al. NEURON
- Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity
- (2022) Ping Shi et al. Frontiers in Oncology
- Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma
- (2022) Ryan Miller et al. Frontiers in Oncology
- Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
- (2022) Shengchao Xu et al. Cell Death & Disease
- Tumor-treating fields in combination with sorafenib curtails the growth of colorectal carcinoma by inactivating AKT/STAT3 signaling
- (2022) Eun Ho Kim et al. Translational Cancer Research
- Transpathology: molecular imaging-based pathology
- (2021) Mei Tian et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses
- (2021) Ke Xu et al. IMMUNITY
- Permeabilizing Cell Membranes with Electric Fields
- (2021) Alondra A. Aguilar et al. Cancers
- Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic
- (2021) Na Tosha N. Gatson et al. Frontiers in Oncology
- TRP Channels in Brain Tumors
- (2021) Giorgia Chinigò et al. Frontiers in Cell and Developmental Biology
- Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial
- (2021) N. Mikic et al. BMC CANCER
- Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
- (2021) Guoqiang Sun et al. Frontiers in Cell and Developmental Biology
- Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic
- (2021) Vladimir A. Ljubimov et al. ADVANCED DRUG DELIVERY REVIEWS
- Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study
- (2021) Hao Wu et al. CNS Neuroscience & Therapeutics
- Potassium channel-driven bioelectric signalling regulates metastasis in triple-negative breast cancer
- (2021) Samantha L. Payne et al. EBioMedicine
- Case report: tumor-treating fields prolongs IDH-mutant anaplastic astrocytoma progression-free survival and pathological evolution to glioblastoma
- (2021) Yi Lin et al. Annals of Translational Medicine
- Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
- (2020) Tali Voloshin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
- (2020) Jan-Michael Werner et al. MOLECULES
- Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
- (2020) Felix Bokstein et al. Frontiers in Oncology
- An overview on anti-tubulin agents for the treatment of lymphoma patients
- (2020) Marilia Barreca et al. PHARMACOLOGY & THERAPEUTICS
- A Theoretical Study on the Biophysical Mechanisms by Which Tumor Treating Fields Affect Tumor Cells During Mitosis
- (2020) Xing Li et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [18F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression
- (2020) Chirag B. Patel et al. NEOPLASIA
- Brain metastases
- (2019) Achal Singh Achrol et al. Nature Reviews Disease Primers
- Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study
- (2019) Guangrong Lu et al. Frontiers in Neurology
- Blood Brain Barrier (BBB) Integrity Is Affected By Tumor Treating Fields (TTFields) in Vitro and In Vivo
- (2019) A.F. Kessler et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells
- (2019) Eun Ho Kim et al. ONCOGENE
- Tumor treating fields cause replication stress and interfere with DNA replication fork maintenance: Implications for cancer therapy
- (2019) Narasimha Kumar Karanam et al. Translational Research
- Selective autophagy maintains centrosome integrity and accurate mitosis by turnover of centriolar satellites
- (2019) Søs Grønbæk Holdgaard et al. Nature Communications
- Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
- (2019) Lazaros Lazaridis et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial
- (2019) Giovanni L Ceresoli et al. LANCET ONCOLOGY
- Amino Acid PET Imaging of the Early Metabolic Response During Tumor-Treating Fields (TTFields) Therapy in Recurrent Glioblastoma
- (2018) Edit Bosnyák et al. CLINICAL NUCLEAR MEDICINE
- Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience
- (2018) Garry Ceccon et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Electrochemotherapy as a New Modality in Interventional Oncology: A Review
- (2018) Ute Probst et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma
- (2018) Martin J. B. Taphoorn et al. JAMA Oncology
- Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot study
- (2018) Ignace Vergote et al. GYNECOLOGIC ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
- (2018) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy
- (2018) Yunhui Jo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial
- (2018) S. A. Toms et al. JOURNAL OF NEURO-ONCOLOGY
- AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
- (2018) Anna Shteingauz et al. Cell Death & Disease
- Epidemiology and Overview of Gliomas
- (2018) Mary Elizabeth Davis Seminars in Oncology Nursing
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
- (2017) Weixing Zhao et al. NATURE
- Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells
- (2017) Moshe Giladi et al. Radiation Oncology
- Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines
- (2017) Narasimha Kumar Karanam et al. Cell Death & Disease
- Biological activity of tumor-treating fields in preclinical glioma models
- (2017) Manuela Silginer et al. Cell Death & Disease
- Thirty years of phase I radiochemotherapy trials: Latest development
- (2016) Romain Rivoirard et al. EUROPEAN JOURNAL OF CANCER
- Personalized Treatment for a Patient With aBRAFV600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From Ganglioglioma
- (2016) Silviya K. Meletath et al. Journal of the National Comprehensive Cancer Network
- Amino acid PET for brain tumours — ready for the clinic?
- (2016) Karl-Josef Langen et al. Nature Reviews Neurology
- TTFields: where does all the skepticism come from?
- (2016) Wolfgang Wick NEURO-ONCOLOGY
- The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
- (2016) F. Bernard-Arnoux et al. NEURO-ONCOLOGY
- Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation
- (2016) Eun Ho Kim et al. Oncotarget
- Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis
- (2016) Eun Ho Kim et al. Oncotarget
- FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair
- (2016) Zeina Kais et al. Cell Reports
- Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma
- (2015) E T Wong et al. BRITISH JOURNAL OF CANCER
- Treatment of Brain Metastases
- (2015) Xuling Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Treating Fields Perturb the Localization of Septins and Cause Aberrant Mitotic Exit
- (2015) Nidhi Gera et al. PLoS One
- PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2
- (2015) Timothy H. Witney et al. Science Translational Medicine
- Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells
- (2015) Moshe Giladi et al. Scientific Reports
- SIRT2knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors
- (2014) Toshiaki Inoue et al. FEBS Journal
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma
- (2014) Mario E. Lacouture et al. SEMINARS IN ONCOLOGY
- Magnetic Resonance Assessment of Response to Therapy: Tumor Change Measurement, Truth Data and Error Sources
- (2014) Edward F. Jackson et al. Translational Oncology
- Tumor treating fields: a new frontier in cancer therapy
- (2013) Angela M. Davies et al. Annals of the New York Academy of Sciences
- Molecular mechanisms of ATP secretion during immunogenic cell death
- (2013) I Martins et al. CELL DEATH AND DIFFERENTIATION
- Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields
- (2013) Moshe Giladi et al. PANCREATOLOGY
- Regulation of Cell Behavior and Tissue Patterning by Bioelectrical Signals: Challenges and Opportunities for Biomedical Engineering
- (2012) Michael Levin et al. Annual Review of Biomedical Engineering
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- A Phase I Study of the Combination of Sorafenib With Temozolomide and Radiation Therapy for the Treatment of Primary and Recurrent High-Grade Gliomas
- (2012) Robert B. Den et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The septin cytoskeleton facilitates membrane retraction during motility and blebbing
- (2012) Julia K. Gilden et al. JOURNAL OF CELL BIOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs
- (2009) Eilon D. Kirson et al. CLINICAL & EXPERIMENTAL METASTASIS
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
- (2009) F. M. Iwamoto et al. NEUROLOGY
- Tumor recurrence and malignant progression of gangliogliomas
- (2008) Michael Majores et al. CANCER
- Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
- (2008) Dieta Brandsma et al. LANCET ONCOLOGY
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
- Amoeboid T lymphocytes require the septin cytoskeleton for cortical integrity and persistent motility
- (2008) Aaron J. Tooley et al. NATURE CELL BIOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
- A Pilot Study with Very Low-Intensity, Intermediate-Frequency Electric Fields in Patients with Locally Advanced and/or Metastatic Solid Tumors
- (2008) Marc Salzberg et al. ONKOLOGIE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now